16 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Exploring Arylidene-Indolinone Ligands of Autophagy Proteins LC3B and GABARAP.
Tufts University
PCSK9 Targeted Autophagosome-Tethering Compounds: Design, Synthesis, and Antiatherosclerosis Evaluation.
Fudan University
Autophagy modulation in cancer therapy: Challenges coexist with opportunities.
Sichuan University
Discovery of 2,4-quinazolinedione derivatives as LC3B recruiters in the facilitation of protein complex degradations.
Hangzhou Institute for Advanced Study
Discovery of autophagy-tethering compounds as potent NLRP3 degraders for IBD Immunotherapy.
Fudan University
Structure-Based Design and Discovery of a Potent and Cell-Active LC3A/B Covalent Inhibitor.
Fudan University
Facilitating the development of molecular glues: Opportunities from serendipity and rational design.
Sichuan University
Discovery of Novel PDEδ Autophagic Degraders: A Case Study of Autophagy-Tethering Compound (ATTEC).
East China University of Science and Technology
Targeted Degradation of Alpha-Synuclein by Autophagosome-Anchoring Chimera Peptides.
Sun Yat-Sen University
The Emerging Landscape of Small-Molecule Therapeutics for the Treatment of Huntington's Disease.
Aligarh Muslim University
Ispinesib as an Effective Warhead for the Design of Autophagosome-Tethering Chimeras: Discovery of Potent Degraders of Nicotinamide Phosphoribosyltransferase (NAMPT).
Second Military Medical University
Demonstrating Ligandability of the LC3A and LC3B Adapter Interface.
Goethe-University Frankfurt
